| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total other income (expense), net | 11,967 | 16,998 | ||
| Net income (loss) | -3,729,128 | -1,733,517 | ||
| Deemed dividend related to warrants down round provision | - | 0 | ||
| Net loss attributable to noncontrolling interests | - | -166 | ||
| Net income (loss) attributable to common stockholders | -3,729,128 | -1,733,351 | ||
| Net income (loss) per share attributable to common stockholders, basic | -1.29 | -0.79 | ||
| Net income (loss) per share attributable to common stockholders, diluted | -1.29 | -0.79 | ||
| Weighted average common shares outstanding, basic | 2,886,059 | 2,202,299 | ||
| Weighted average common shares outstanding, diluted | 2,886,059 | 2,202,299 | ||
Ensysce Biosciences, Inc. (ENSCW)
Ensysce Biosciences, Inc. (ENSCW)